- Home
- KRKR vs NEUP Comparison
KRKR vs NEUP Comparison
Compare KRKR & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- NEUP
- Stock Information
- Founded
- KRKR 2010
- NEUP 1996
- Country
- KRKR China
- NEUP United States
- Employees
- KRKR N/A
- NEUP N/A
- Industry
- KRKR Business Services
- NEUP
- Sector
- KRKR Consumer Discretionary
- NEUP
- Exchange
- KRKR Nasdaq
- NEUP Nasdaq
- Market Cap
- KRKR 12.2M
- NEUP 12.7M
- IPO Year
- KRKR 2019
- NEUP N/A
- Fundamental
- Price
- KRKR $5.59
- NEUP $15.52
- Analyst Decision
- KRKR
- NEUP Strong Buy
- Analyst Count
- KRKR 0
- NEUP 2
- Target Price
- KRKR N/A
- NEUP $28.00
- AVG Volume (30 Days)
- KRKR 22.9K
- NEUP 94.7K
- Earning Date
- KRKR 09-26-2025
- NEUP 11-15-2025
- Dividend Yield
- KRKR N/A
- NEUP N/A
- EPS Growth
- KRKR N/A
- NEUP N/A
- EPS
- KRKR N/A
- NEUP N/A
- Revenue
- KRKR $30,966,526.00
- NEUP $15,649,448.00
- Revenue This Year
- KRKR $182.55
- NEUP N/A
- Revenue Next Year
- KRKR N/A
- NEUP N/A
- P/E Ratio
- KRKR N/A
- NEUP N/A
- Revenue Growth
- KRKR N/A
- NEUP N/A
- 52 Week Low
- KRKR $2.76
- NEUP $2.90
- 52 Week High
- KRKR $21.36
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- KRKR 35.17
- NEUP 53.94
- Support Level
- KRKR $5.93
- NEUP $14.64
- Resistance Level
- KRKR $6.32
- NEUP $17.90
- Average True Range (ATR)
- KRKR 0.32
- NEUP 2.17
- MACD
- KRKR -0.22
- NEUP -0.31
- Stochastic Oscillator
- KRKR 0.24
- NEUP 46.59
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.